Clinical Trial Update: Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Word（STONE）

View source ↗

Summary

This clinical trial update reports long-term safety and treatment outcomes of intravitreal conbercept for wet age-related macular degeneration in Chinese patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• Conbercept (KH902) (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Wet Age-related Macular Degeneration (wAMD) | Status: UNKNOWN